Heat shock proteins are involved in the folding of many cellular proteins and are indirectly
implicated in the development of various diseases. The Hsp90 family contains numerous so
called client proteins that have been identified as oncogenic drivers. In the endoplasmic
reticulum, glucose regulated protein 94 (Grp94) is present as one of the isoforms of the
Hsp90 family. Selective inhibition of this isoform could affect the folding of certain
oncogenic proteins without interfering with the activity of other Hsp90 isoforms. The aim of
this master’s thesis was to clone the gene HSP90B1, express human Grp94 and to determine
the binding affinity of two compounds towards Grp94: non-selective C-terminal domain
inhibitor novobiocin, and the compound UL-Hsp90-1. The latter was synthesized at the
Faculty of Pharmacy, University of Ljubljana, for the purpose of inhibiting members of the
Hsp90 family at the C-terminal domain.
The HSP90B1 gene was inserted into the bacterial expression vector pET28. After
unsuccessful attempts with classical molecular cloning, the construct pET28 containing the
HSP90B1 gene was successfully prepared using Gibson assembly. Expression was induced
in the E. coli strain NiCo21 (DE3). For successful biosynthesis of full-length Grp94, co
transformation of bacteria with the plasmid pRARE2 was required, providing transfer
ribonucleic acids for codons that are rare in the chosen bacterial strain. Expression conditions
were further optimized and it was determined that induction with 0.1 mM isopropyl β-d-1
thiogalactopyranoside in 2× YT medium at 16 °C was sufficient for protein expression.
Protein isolation was performed in two steps: first by metal-chelate affinity chromatography,
followed by size-exclusion chromatography. The presence of Grp94 was confirmed by
sodium dodecyl sulfate polyacrylamide gel electrophoresis and western blot analysis.
Protein concentration was determined using the Bradford assay. The isolated human Grp94
was then used to assess the binding affinity of the selected compounds by microscale
thermophoresis. A dissociation constant for novobiocin binding to Grp94 was successfully
determined (217.5 ± 80.17 µM), while no binding constant could be determined for UL
Hsp90-1 under the same conditions. This could indicate that UL-Hsp90-1 does not bind to
Grp94.
|